정밀의료 시장 규모, 점유율, 성장 분석 : 기술별, 제품별, 시퀀싱 기술별, 투여 경로별, 용도별, 최종 용도별, 지역별 - 업계 예측(2026-2033년)

Precision Medicine Market size was valued at USD 95.55 Billion in 2024 and is poised to grow from USD 110.93 Billion in 2025 to USD 366.2 Billion by 2033, growing at a CAGR of 16.1% during the forecast period (2026-2033).

Precision medicine revolutionizes healthcare by recognizing that individuals with identical conditions may respond differently due to various factors, including genetics, symptoms, and environmental influences. This approach facilitates customized treatment plans by enhancing the understanding of each patient's unique molecular profile, often integrating panomics and systems biology in the diagnostic process. Targeted therapies derived from these insights provide more effective interventions while minimizing unnecessary treatments and costs. The burgeoning field of genomics significantly contributes to this growth, as the potential of genetically tailored medications gains recognition. The rising importance of companion diagnostics, which employ genetic testing, further accelerates market expansion. Additionally, an increasing number of specialized medications approved by regulatory bodies continues to drive precision medicine's adoption in clinical practice.

Top-down and bottom-up approaches were used to estimate and validate the size of the Precision Medicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Precision Medicine Market Segments Analysis

Global Precision Medicine Market is segmented by Technology, Product, Sequencing Technology, Route of Administration, Application, End-Use and region. Based on Technology, the market is segmented into Bioinformatics, Big Data Analytics, Drug Discovery, Gene Sequencing, Companion Diagnostics and Others. Based on Product, the market is segmented into Consumables, Instruments and Services. Based on Sequencing Technology, the market is segmented into Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, Chain Termination Sequencing and Nanopore Sequencing. Based on Route of Administration, the market is segmented into Oral, Injectable, By Drugs, Alectinib, Osimertinib, Mepolizumab, Aripiprazole Lauroxil and Others. Based on Application, the market is segmented into CNS, Immunology, Oncology, Respiratory and Others. Based on End-Use, the market is segmented into Diagnostic Companies, Pharmaceutical Companies, Healthcare IT companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Precision Medicine Market

The Precision Medicine market is significantly driven by the extensive application of diagnostic tests that analyze a patient's genetic profile, focusing on individual variations, genetic mutations, and other differences. This approach enables the development of tailored treatment plans that cater specifically to each patient's unique genetic makeup. Furthermore, the growing accessibility of prenatal and cancer screening tests, along with the rise of direct-to-consumer genetic testing, is contributing to the increasing demand for genetic testing services. This trend highlights a shift towards more personalized healthcare solutions, fostering advancements in precision medicine and improving patient outcomes.

Restraints in the Precision Medicine Market

The Precision Medicine market faces notable challenges due to significant privacy and security issues associated with the extensive collection and analysis of personal genetic and health data. The potential for sensitive information to be compromised or misused poses a real threat, jeopardizing the trust that patients place in healthcare providers and researchers. This concern not only affects individual willingness to share personal data but also contributes to a growing debate surrounding the ethical implications of utilizing precision medicine solutions. As these privacy and security apprehensions persist, they may hinder the advancement and adoption of innovative approaches in the field of precision medicine.

Market Trends of the Precision Medicine Market

The Precision Medicine market is experiencing a transformative trend as healthcare shifts towards personalized treatment methodologies, significantly influenced by genetic insights. Key developments include the integration of genetic testing and molecular diagnostics into clinical practice, allowing for more tailored treatment plans that cater to individual patient profiles. Advances in DNA sequencing technology and molecular profiling are enhancing disease diagnosis and management, leading to improved patient outcomes. As healthcare providers increasingly embrace these innovations, a growing emphasis on targeted therapies is observed, further solidifying the role of precision medicine in addressing complex diseases with greater efficacy and specificity.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies

Global Precision Medicine Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Bioinformatics
• Big Data Analytics
• Drug Discovery
• Gene Sequencing
• Companion Diagnostics
• Others

Global Precision Medicine Market Size by Product & CAGR (2026-2033)

• Market Overview
• Consumables
• Instruments
• Services

Global Precision Medicine Market Size by Sequencing Technology & CAGR (2026-2033)

• Market Overview
• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Sequencing by Ligation
• Pyrosequencing
• Single Molecule Real Time Sequencing
• Chain Termination Sequencing
• Nanopore Sequencing

Global Precision Medicine Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Injectable
• By Drugs
• Alectinib
• Osimertinib
• Mepolizumab
• Aripiprazole Lauroxil
• Others

Global Precision Medicine Market Size by Application & CAGR (2026-2033)

• Market Overview
• CNS
• Immunology
• Oncology
• Respiratory
• Others

Global Precision Medicine Market Size by End-Use & CAGR (2026-2033)

• Market Overview
• Diagnostic Companies
• Pharmaceutical Companies
• Healthcare IT companies
• Others

Global Precision Medicine Market Size & CAGR (2026-2033)

• North America (Technology, Product, Sequencing Technology, Route of Administration, Application, End-Use)
  • US
  • Canada
• Europe (Technology, Product, Sequencing Technology, Route of Administration, Application, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product, Sequencing Technology, Route of Administration, Application, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product, Sequencing Technology, Route of Administration, Application, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product, Sequencing Technology, Route of Administration, Application, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol Myers Squibb (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Almac Group Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ab-Biotics Sa (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations